United States Pharmaceuticals

Invivyd Inc (IVVD)

Track

The most recent insider trading activity at Invivyd Inc. occurred on February 18, 2026. During mid-February 2026, multiple executives, including the CFO, Chief Commercial Officer, and Chief Legal Officer, executed a series of planned and proposed share sales. No insider trading activity has been reported within the last three months.
Ticker: IVVD Exchange: NMS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Invivyd Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Planned sale 18 Feb 2026
Value US$1,647,722.93 | Price 371.24 | Shares 90,507 (+4.4%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-18 2026-02-18 PlS Planned sale
Allen Robert D. III

Chief Scientific Officer

Officer
90,507 +4.4%
371.24
US$1,647,723 		90,507 +4.4% 371.24 US$1,647,723
2026-02-18 2026-02-18 PlS Planned sale
Green Julie

Chief Human Resources Officer

Officer
42,154 +27.9%
155.24
US$1,132,369 		42,154 +27.9% 155.24 US$1,132,369
2026-02-18 2026-02-18 PlS Planned sale
Duke William E.

Chief Financial Officer

Officer
38,854 +46.7%
101.43
US$1,804,696 		38,854 +46.7% 101.43 US$1,804,696
2026-02-18 2026-02-18 PlS Planned sale
Lee Timothy Edward

Chief Commercial Officer

Officer
20,964 -15.1%
1.58
US$33,077 		20,964 -15.1% 1.58 US$33,077
2026-02-18 2026-02-18 PlS Planned sale
Andersen Jill

Chief Legal Officer, Secretary

Officer
34,939 -16.1%
1.58
US$55,127 		34,939 -16.1% 1.58 US$55,127
2026-02-18 2026-02-17 PlS Planned sale
Allen Robert D. III

Chief Scientific Officer

Officer
18,189 -12.0%
1.54
US$28,004 		18,189 -12.0% 1.54 US$28,004
2026-02-18 2026-02-17 PlS Planned sale
Green Julie

Chief Human Resources Officer

Officer
19,663 -13.3%
1.54
US$30,273 		19,663 -13.3% 1.54 US$30,273
2026-02-18 2026-02-17 PlS Planned sale
Duke William E.

Chief Financial Officer

Officer
19,663 -13.3%
1.54
US$30,273 		19,663 -13.3% 1.54 US$30,273
2026-02-18 2026-02-17 PlS Planned sale
Lee Timothy Edward

Chief Commercial Officer

Officer
19,663 -12.4%
1.54
US$30,273 		19,663 -12.4% 1.54 US$30,273
2026-02-18 2026-02-17 PlS Planned sale
Andersen Jill

Chief Legal Officer, Secretary

Officer
32,771 -13.1%
1.54
US$50,454 		32,771 -13.1% 1.54 US$50,454
2026-02-17 2026-02-17 PrS Proposed sale
Green Julie

Officer

Officer
39,600
1.56
US$61,776 		39,600 1.56 US$61,776
2026-02-17 2026-02-17 PrS Proposed sale
Allen Robert D. III

Officer

Officer
36,630
1.56
US$57,143 		36,630 1.56 US$57,143
2026-02-17 2026-02-17 PrS Proposed sale
Lee Timothy Edward

Officer

Officer
39,600
1.56
US$61,776 		39,600 1.56 US$61,776
2026-02-17 2026-02-17 PrS Proposed sale
Duke William E.

Officer

Officer
39,600
1.56
US$61,776 		39,600 1.56 US$61,776
2026-02-17 2026-02-17 PrS Proposed sale
Andersen Jill

Officer

Officer
66,000
1.56
US$102,960 		66,000 1.56 US$102,960
2025-12-23 2025-12-23 PrS Proposed sale
ADIMAB, LLC

10% Stockholder

Large shareholder
192,320
3.00
US$577,498 		192,320 3.00 US$577,498
2025-11-20 2025-11-19 B Purchase
0.6
MCLAUGHLIN KEVIN F
Non-Executive Director
50,000 +inf%
2.50
US$125,000 		50,000 +inf% 2.50 US$125,000
2025-11-17 2025-11-17 PrS Proposed sale
ADIMAB, LLC

10% Stockholder

Large shareholder
1,233,416
3.00
US$3,703,455 		1,233,416 3.00 US$3,703,455
2025-08-19 2025-08-19 PlS Planned sale
Duke William E.

Chief Financial Officer

Officer
29,643 -37.5%
0.57
US$16,796 		29,643 -37.5% 0.57 US$16,796
2025-08-19 2025-08-19 PlS Planned sale
Andersen Jill

Chief Legal Officer, Secretary

Officer
49,402 -36.9%
0.57
US$27,991 		49,402 -36.9% 0.57 US$27,991
2025-08-19 2025-08-19 PlS Planned sale
Allen Robert D. III

Chief Scientific Officer

Officer
27,420 -34.1%
0.57
US$15,536 		27,420 -34.1% 0.57 US$15,536
2025-08-19 2025-08-19 PlS Planned sale
Lee Timothy Edward

Chief Commercial Officer

Officer
29,643 -33.3%
0.57
US$16,796 		29,643 -33.3% 0.57 US$16,796
2025-08-19 2025-08-19 PlS Planned sale
Green Julie

Chief Human Resources Officer

Officer
29,643 -37.5%
0.57
US$16,796 		29,643 -37.5% 0.57 US$16,796
2025-08-19 2025-08-18 PlS Planned sale
Duke William E.

Chief Financial Officer

Officer
20,013 -20.2%
0.65
US$13,012 		20,013 -20.2% 0.65 US$13,012
2025-08-19 2025-08-18 PlS Planned sale
Andersen Jill

Chief Legal Officer, Secretary

Officer
33,352 -19.9%
0.65
US$21,685 		33,352 -19.9% 0.65 US$21,685
2025-08-19 2025-08-18 PlS Planned sale
Allen Robert D. III

Chief Scientific Officer

Officer
18,512 -18.7%
0.65
US$12,037 		18,512 -18.7% 0.65 US$12,037
2025-08-19 2025-08-18 PlS Planned sale
Lee Timothy Edward

Chief Commercial Officer

Officer
20,013 -18.4%
0.65
US$13,012 		20,013 -18.4% 0.65 US$13,012
2025-08-19 2025-08-18 PlS Planned sale
Green Julie

Chief Human Resources Officer

Officer
20,013 -20.2%
0.65
US$13,012 		20,013 -20.2% 0.65 US$13,012
2025-08-18 2025-08-18 PrS Proposed sale
Green Julie

Officer

Officer
39,600
0.71
US$28,001 		39,600 0.71 US$28,001
2025-08-18 2025-08-18 PrS Proposed sale
Andersen Jill

Officer

Officer
66,000
0.71
US$46,669 		66,000 0.71 US$46,669
2025-08-18 2025-08-18 PrS Proposed sale
Allen Robert D. III

Officer

Officer
36,631
0.71
US$25,902 		36,631 0.71 US$25,902
2025-08-18 2025-08-18 PrS Proposed sale
Lee Timothy Edward

Officer

Officer
39,600
0.71
US$28,001 		39,600 0.71 US$28,001
2025-08-18 2025-08-18 PrS Proposed sale
Duke William E.

Officer

Officer
39,601
0.71
US$28,002 		39,601 0.71 US$28,002
2024-12-31 2024-12-31 S Sale
1.4
MCGUIRE TERRANCE
Non-Executive Director
103,474 -3.3%
0.45
US$46,098 		103,474 -3.3% 0.45 US$46,098
2024-12-31 2024-12-30 S Sale
1.4
MCGUIRE TERRANCE
Non-Executive Director
86,545 -2.7%
0.48
US$41,784 		86,545 -2.7% 0.48 US$41,784
2024-12-31 2024-12-27 S Sale
1.4
MCGUIRE TERRANCE
Non-Executive Director
83,744 -2.5%
0.52
US$43,647 		83,744 -2.5% 0.52 US$43,647
2024-12-26 2024-12-26 S Sale
1.4
MCGUIRE TERRANCE
Non-Executive Director
83,817 -2.4%
0.54
US$45,563 		83,817 -2.4% 0.54 US$45,563
2024-12-26 2024-12-24 S Sale
1.4
MCGUIRE TERRANCE
Non-Executive Director
68,161 -2.0%
0.51
US$34,503 		68,161 -2.0% 0.51 US$34,503
2024-12-26 2024-12-23 S Sale
1.4
MCGUIRE TERRANCE
Non-Executive Director
75,776 -2.1%
0.45
US$34,076 		75,776 -2.1% 0.45 US$34,076
2024-12-26 2024-12-20 S Sale
1.4
MCGUIRE TERRANCE
Non-Executive Director
119,805 -3.2%
0.42
US$50,725 		119,805 -3.2% 0.42 US$50,725
2024-12-20 2024-12-20 PrS Proposed sale
POLARIS PARTNERS IX, LP

Director

Non-Executive Director
1,000,000
0.44
US$443,900 		1,000,000 0.44 US$443,900
2024-12-19 2024-12-19 S Sale
1.4
MCGUIRE TERRANCE
Non-Executive Director
152,067 -4.0%
0.43
US$65,951 		152,067 -4.0% 0.43 US$65,951
2024-12-19 2024-12-18 S Sale
1.4
MCGUIRE TERRANCE
Non-Executive Director
74,764 -1.9%
0.47
US$35,087 		74,764 -1.9% 0.47 US$35,087
2024-12-19 2024-12-17 S Sale
1.4
MCGUIRE TERRANCE
Non-Executive Director
97,410 -2.4%
0.48
US$46,757 		97,410 -2.4% 0.48 US$46,757
2024-12-16 2024-12-16 S Sale
1.4
MCGUIRE TERRANCE
Non-Executive Director
65,359 -1.6%
0.47
US$30,510 		65,359 -1.6% 0.47 US$30,510
2024-12-16 2024-12-12 S Sale
1.4
MCGUIRE TERRANCE
Non-Executive Director
125,000 -3.0%
0.58
US$72,875 		125,000 -3.0% 0.58 US$72,875
2024-12-11 2024-12-11 S Sale
1.4
MCGUIRE TERRANCE
Non-Executive Director
160,400 -3.7%
0.59
US$94,812 		160,400 -3.7% 0.59 US$94,812
2024-12-11 2024-12-10 S Sale
1.4
MCGUIRE TERRANCE
Non-Executive Director
175,000 -3.9%
0.59
US$103,005 		175,000 -3.9% 0.59 US$103,005
2024-12-11 2024-12-09 S Sale
1.4
MCGUIRE TERRANCE
Non-Executive Director
150,000 -3.2%
0.61
US$91,560 		150,000 -3.2% 0.61 US$91,560
2024-12-09 2024-12-09 PrS Proposed sale
POLARIS PARTNERS IX, LP

Director

Non-Executive Director
1,000,000
0.61
US$610,400 		1,000,000 0.61 US$610,400
2024-05-31 2024-05-29 S Sale
1.4
MCGUIRE TERRANCE
Non-Executive Director
112,381 -2.3%
1.66
US$186,575 		112,381 -2.3% 1.66 US$186,575
2024-05-29 2024-05-29 PrS Proposed sale
Polaris Partners IX, L.P.

Director

Non-Executive Director
1,000,000
0.19
US$186,575 		1,000,000 0.19 US$186,575
2024-05-16 2024-05-16 PrS Proposed sale
0.5
DAVID NEIL HERING

Officer

Officer
10,000
2.43
US$24,339 		10,000 2.43 US$24,339
2024-01-22 2024-01-19 S Sale
Adimab, LLC
Large shareholder
5,000,000 -18.7%
3.95
US$19,750,000 		5,000,000 -18.7% 3.95 US$19,750,000
2024-01-19 2024-01-19 PrS Proposed sale
ADIMAB, LLC

10% Stockholder

Large shareholder
5,000,000
3.95
US$19,750,000 		5,000,000 3.95 US$19,750,000
2022-09-01 2022-09-01 B Purchase
0.5
Hering David

Chief Executive Officer

Executive Director
8,000 +inf%
4.52
US$36,160 		8,000 +inf% 4.52 US$36,160
2022-08-19 2022-08-19 B Purchase
0.9
Elia Marc

See Footnote 5

Non-Executive Director
584,451 +6.7%
4.62
US$2,700,164 		584,451 +6.7% 4.62 US$2,700,164
2022-08-19 2022-08-18 B Purchase
0.9
Elia Marc

See Footnote 5

Non-Executive Director
1,265,549 +17.1%
4.31
US$5,454,516 		1,265,549 +17.1% 4.31 US$5,454,516
2022-08-19 2022-08-17 B Purchase
0.9
Elia Marc

See Footnote 5

Non-Executive Director
1,000,000 +15.6%
4.04
US$4,040,000 		1,000,000 +15.6% 4.04 US$4,040,000
2021-08-12 2021-08-10 B Purchase
2.5
Royan Ajay
Non-Executive Director Large shareholder
1,997,000 +21.6%
17.00
US$33,949,000 		1,997,000 +21.6% 17.00 US$33,949,000
Explore more

More insider trading research around Invivyd Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America